FDA denies a petition to exempt certain radiology AI software from 510(k) review, stressing ongoing regulatory oversight.
Key Details
- 1FDA rejected Harrison.ai's petition seeking 510(k) exemption for four types of radiology AI (CADx, CADe, CADt, CADe/x) under specific classifications.
- 2At least 255 radiology AI devices received 510(k) clearance in 2025 alone, per FDA records.
- 3FDA clarified prior clearance does not guarantee manufacturer competence for future device development.
- 4Manufacturer-proposed self-evaluation and risk plans were dismissed due to insufficient FDA oversight mechanisms.
- 5Most public comments opposed the exemption, and FDA detailed significant differences between CADe, CADx, and CADe/x devices impacting regulatory needs.
- 6The agency emphasized vulnerabilities in relying on end-users (radiologists) to catch all performance issues.
Why It Matters
This decision underscores the FDA’s commitment to robust regulatory oversight for radiology AI, potentially affecting product development timelines and market strategies. The nuanced treatment of different device categories and the rejection of broad user detection arguments highlight stringent evidentiary requirements that developers must meet.
Source
AuntMinnie
Related News
•AuntMinnie
AI Advances in Breast Cancer Risk, CEUS Training Updates, and Imaging AI Variability
This week's top radiology news reviews AI advances in breast and lung cancer risk prediction, new CEUS training standards, and prostate screening updates with imaging modalities.
•AuntMinnie
Mammography AI Model Outperforms Rivals for 10-Year Breast Cancer Risk
A new mammography-based AI model predicts 10-year breast cancer risk more accurately than established clinical and AI models.
•Radiology Business
SimonMed Imaging Introduces Paid AI Add-Ons for Routine Exams
SimonMed Imaging is launching new AI-powered elective services for routine imaging exams with additional out-of-pocket costs for patients.